| 02.05 12:47 | dpa-AFX: Zimmer Biomet Holdings Inc. Q1 Profit Decreases, but beats estimates |
| 02.05 12:41 | dpa-AFX: *ZIMMER BIOMET CONTINUES TO EXPECT FY24 REPORTED REVENUE GROWTH OF 4.5% - 5.5% |
| 02.05 12:41 | dpa-AFX: *ZIMMER BIOMET CONTINUES TO EXPECT FY24 ADJ. EPS OF $8.00 - $8.15 |
| 02.05 12:39 | dpa-AFX: *ZIMMER BIOMET Q1 NET SALES $1.889 BLN VS. $1.831 BLN LAST YEAR |
| 02.05 12:38 | dpa-AFX: *ZIMMER BIOMET Q1 OPERATING PROFIT $265.9 MLN VS. $327.3 MLN LAST YEAR |
| 02.05 12:38 | dpa-AFX: *ZIMMER BIOMET Q1 NET INCOME $172.4 MLN VS. $232.5 MLN LAST YEAR |
| 02.05 12:33 | dpa-AFX: *ZIMMER BIOMET Q1 EPS $0.84 VS. $1.11 LAST YEAR |
| 22.02 13:48 | dpa-AFX: Zimmer Biomet Receives FDA's 510(k) Clearance For ROSA Shoulder System |
| 22.02 13:39 | dpa-AFX: *ZIMMER BIOMET RECEIVES FDA CLEARANCE FOR ROSA SHOULDER SYSTEM |
| 21.02 13:04 | dpa-AFX: *ZIMMER BIOMET DECLARES QUARTERLY CASH DIVIDEND OF $0.24/SHR; RECORD MAR 29/PAYABLE ON OR ABOUT APRIL 30 |
| 21.02 13:01 | dpa-AFX: *ZIMMER BIOMET HOLDINGS INC. (ZBH) DECLARES $ 0.24 DIVIDEND FOR Q1 24, RECORD DATE 3/29/2024 |
| 12.02 13:32 | dpa-AFX: *ZIMMER BIOMET SIGNS GLOBAL HEALTH EQUITY NETWORK'S ZERO HEALTH GAPS PLEDGE |
| 08.02 13:34 | dpa-AFX: Zimmer Biomet Holdings Q4 23 Earnings Conference Call At 8:30 AM ET |
| 08.02 12:41 | dpa-AFX: ROUNDUP: Zimmer Biomet Guides FY24 Above Estimates |
| 08.02 12:39 | dpa-AFX: *ZIMMER BIOMET COMPLETES $500 MLN SHARE BUYBACK PROGRAM |
| 08.02 12:39 | dpa-AFX: *ZIMMER BIOMET APPOINTS LOUIS A. SHAPIRO TO BOARD |
| 08.02 12:38 | dpa-AFX: *ZIMMER BIOMET Q4 ADJ. EPS $2.20 VS. $1.88 LAST YEAR |
| 08.02 12:37 | dpa-AFX: *ZIMMER BIOMET EXPECTS FY24 ADJ. EPS OF $8.00 - $8.15 |
| 08.02 12:37 | dpa-AFX: *ZIMMER BIOMET EXPECTS FY24 REPORTED REVENUE GROWTH OF 4.5% - 5.5% |
| 08.02 12:35 | dpa-AFX: *ZIMMER BIOMET Q4 NET SALES $1.940 BLN VS. $1.825 BLN LAST YEAR |
|
|
